Latest News

In early January 2026, Upstream Bio, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference, while analysts initiated and upgraded coverage around its asthma candidate verekitug and the upcoming Phase 2 VALINAT readout. The combination of growing physician enthusiasm for long-acting TSLP inhibition and expectations for the VALINAT data has sharpened investor focus on Upstream Bio’s clinical pipeline. Against this backdrop, we’ll examine how physician interest in verekitug and...

In recent weeks, Mineralys Therapeutics reported stronger-than-expected third-quarter 2025 results while advancing its lead drug lorundrostat toward a New Drug Application for uncontrolled hypertension and chronic kidney disease. At the same time, senior executives executed pre-arranged Rule 10b5-1 stock sales as lorundrostat gained recognition in JAMA’s Research of the Year Roundup and the company presented at the 15th Annual LifeSci Partners Corporate Access Event. Against this backdrop,...

Why Zurich Insurance Group’s risk warnings are back in focus Zurich Insurance Group (SWX:ZURN) is back on investors’ radar after senior executives highlighted rising geopolitical, technological, and societal risks, ahead of the group’s upcoming presentation at the Octavian Seminar 2026 in Davos. See our latest analysis for Zurich Insurance Group. Zurich’s share price at CHF 578.8 has slipped over the year to date, yet a 90 day share price return of 4.25% sits alongside a 1 year total...

Key Insights Using the Dividend Discount Model, SSE fair value estimate is UK£18.69 SSE is estimated to be 24...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Key Insights Given the large stake in the stock by institutions, Larsen & Toubro's stock price might be vulnerable to...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies...

On January 15, 2026, Galaxy Digital Inc. announced it had completed ERCOT’s Large Load Interconnection Study and secured approval for an additional 830 megawatts of computing demand at its Helios data center campus in West Texas, lifting total approved and contracted power capacity at the site to over 1.6 gigawatts. This substantial power upgrade underpins Galaxy’s ambition to build a multi-tenant, multi-campus, multi-gigawatt platform for AI and high-performance computing workloads, using...

If you are wondering whether First Solar's share price still makes sense after recent moves, you are not alone. This article is designed to help you judge the current value with a clear framework. At a last close of US$243.64, the stock has had a 1.1% decline over the past week, a 5.8% decline over the past month, an 11.2% decline year to date, yet a 27.6% return over 1 year, 47.7% over 3 years and 126.6% over 5 years. This naturally raises questions about how much of the story is already in...

Antero Midstream (AM) has kept its quarterly cash dividend at $0.225 per share, alongside fourth quarter share repurchases and new senior notes offerings that reshape how cash flows between the company and its investors. See our latest analysis for Antero Midstream. At a share price of US$17.84, Antero Midstream has seen a 7 day share price return of 2.94% while its 1 year total shareholder return of 15.25% and 5 year total shareholder return above 200% reflect gradually building momentum...

If you are wondering whether Rezolve AI's recent run makes the stock look cheap or stretched, this article walks through what the current price could imply about its value. The shares last closed at US$4.62, with returns of 24.5% over 7 days, 55.6% over 30 days, 61.0% year to date and 53.5% over 1 year, while the 3 year return sits at a 54.2% decline. Recent price moves have come as Rezolve AI continues to attract attention in the AI and software space, where investor interest can quickly...

Key Insights Significantly high institutional ownership implies Tungsten West's stock price is sensitive to their...

STAAR Surgical recently reshaped its board after shareholders rejected a proposed merger with Alcon, adding three investor-affiliated directors while CEO Stephen Farrell stepped down from the board but remains in the role until January 31, 2026. This shift hands greater influence to major shareholder Broadwood Partners and its allies, signaling potential changes in governance priorities and capital allocation for the standalone company. With Broadwood-backed directors now on the board, we’ll...

H.B. Fuller FY 2025 earnings snapshot H.B. Fuller (FUL) has wrapped up FY 2025 with fourth quarter revenue of US$894.8 million and basic EPS of US$0.55, setting the tone for a year where earnings momentum and margin progression were in focus for investors. The company has seen quarterly revenue move from US$917.9 million in Q3 2024 to the US$788.7 million to US$898.1 million range across the first three quarters of 2025, while basic EPS shifted from US$1.01 in Q3 2024 to US$0.24, US$0.77 and...

If you have been wondering whether Omnicom Group's share price still reflects its underlying business, this article walks through what the current numbers actually say about value. The stock last closed at US$80.84, with returns of 2.6% over the past 7 days, 0.2% over the past 30 days, a 0.6% decline year to date and a 2.3% decline over the past year. This is set against gains of 8.8% over 3 years and 52.6% over 5 years. Recent coverage has focused on how global advertising and marketing...

Why AIRO Group Holdings (AIRO) Is Back on Investors’ Radar Recent coverage around AIRO Group Holdings (AIRO) has zeroed in on its liquidity position and upcoming execution milestones, which together help explain the renewed interest you might be seeing in the stock. See our latest analysis for AIRO Group Holdings. After a sharp 71.65% 30 day share price return and a 42.86% year to date share price return, AIRO’s recent pullback, including a 24.57% 90 day share price decline and softer 1 day...

Why Fugro’s business shift is drawing fresh investor attention Fugro (ENXTAM:FUR) is attracting interest after shifting from traditional surveying to integrated digital services for offshore wind and infrastructure, with a stronger focus on remote operations and recurring asset monitoring. See our latest analysis for Fugro. Recent trading has picked up, with a 7 day share price return of 7.74% and a 30 day gain of 13.61%. However, the 1 year total shareholder return shows a 39.33% decline and...

If you are wondering whether Mercury Systems' recent share price strength still leaves any value on the table, this breakdown is designed to help you weigh the upside against the risks. The stock last closed at US$102.95, with returns of 16.0% over 7 days, 43.4% over 30 days, 35.4% year to date, 140.2% over 1 year and 119.4% over 3 years, which naturally raises questions about how the current price lines up with underlying value. These moves have played out alongside ongoing investor...

ENEOS Holdings, Inc. ( TSE:5020 ) has announced that it will pay a dividend of ¥17.00 per share on the 29th of June...

Last week, Distribution Finance Capital Holdings plc ( LON:DFCH ) insiders, who had purchased shares in the previous 12...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Rheinmetall AG ( ETR:RHM ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. The...

With a price-to-earnings (or "P/E") ratio of 3.8x CT Automotive Group plc ( LON:CTA ) may be sending very bullish...